SensNews April 2020

Sensor100 2020 8 FDA Grants Emergency Use Authorizations for Ultimate Dx, AIT Labs, MicroGenDx CoronavirusTests The US Food and Drug Administration granted separate Emergency Use Authoriza- tions (EUAs) for RT-PCR-based SARS-CoV-2 assays developed by Ultimate Dx,AIT Laboratories, and MicroGenDx. GenomeWeb 27 April Novacyt Inks Supply Contract for CoronavirusTestWith UK Health Agency The partnership with the DHSC reinforces Novacyt's existing support of the UK gov- ernment's five-pillar plan to increase testing for COVID-19, the firm said. Novacyt had announced in April that it is collaborating with AstraZeneca, GlaxoSmithKline, and the University of Cambridge to increase SARS-CoV-2 testing in the UK. GenomeWeb 2 7 April New Biosensor Detects COVID-19Virus in Air A team of researchers from Switzerland has succeeded in developing a novel sensor for detecting the new coronavirus that could be used to measure the concentration of the virus in the environment, such as in places where there are many people or in hospital ventilation systems. HospiMedica 25 April Fingerprint testing firm aims to develop COVID-19 solution Intelligent Fingerprinting – developers of a portable fin- gerprint-based drug screening system – believes the capabili- ties of its technology and portable instrumentation could lead to the development of a COVID-19 test. Med Tech Innovation New s 22 April